Refer to the respective prescribing information for bevacizumab, paclitaxel, and carboplatin for recommended dosing information TECENTRIQ in combination with nab-paclitaxel and carboplatin. Induction phase followed by chemotherapy-free infusions with TECENTRIQ.
of Tecentriq and bevacizumab. Refer to the bevacizumab Product Monograph for full prescribing information on the risks of bleeding events
Prescribing Information for Tecentriq (atezolizumab) is available either via The European Medicines. Agency website at
Full prescribing information for Tecentriq Hybreza will be posted on Drugs@FDA. Efficacy and Safety. The subcutaneous injection of atezolizumab
Tecentriq (Atezolizumab). The purpose of this form is to obtain Have the prescribing physician complete the Physician Information sections.
intravenous formulation of atezolizumab (Tecentriq, Genentech, Inc Full prescribing information for Tecentriq Hybreza will be posted on Drugs
^ FDA updates prescribing information for Keytruda and Tecentriq. U.S. Food and Drug Administration. Retrieved . Public Domain.
See 17 for PATIENT COUNSELING INFORMATION and Medication HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TECENTRIQ safely and effectively. See full prescribing information for TECENTRIQ. TECENTRIQ (atezolizumab) injection, for intravenous use Initial U.S. Approval: 2024
Full prescribing information for Tecentriq Hybreza will be posted on Drugs@FDA. The approval was made on Septem. The content in
Comments